Natco Pharma Ltd
BSE:
NSE:NATCOPHARM
NATCOPHARM Share Price
BSE:
NSE:NATCOPHARM
Pharmaceuticals
Large Cap
₹-
0 (0%)
Market Cap
₹22,492.62Cr
PE Ratio
11.57
Natco Pharma Ltd Performance
▲
▲
▲
▲
Natco Pharma Ltd Fundamentals
Natco Pharma Ltd Delivery and Volume
About Natco Pharma Ltd
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Company's focus is primarily on niche therapeutic areas and comp
| Name | Designation |
|---|---|
| V C Nannapaneni | Chairman & Managing Director |
| Rajeev Nannapaneni | Vice Chairman & CEO |
| PSRK Prasad | Vice President & Director |
| D Linga Rao | President & Director |
| Pavan Bhat | Vice President & Director |
| Venkat Ramesh | Company Sec. & Compli. Officer |
| A D Murthy Chavali | Independent Director |
| B. Lakshminarayana | Independent Director |
| Kantipudi Suma | Independent Director |
| Nitin Jain | Independent Director |
| Vijayabhaskar Dronadula | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Natco Pharma Ltd FAQs
How do I Buy Natco Pharma Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Natco Pharma Ltd shares in BlinkX.
What is the Share Price of Natco Pharma Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Natco Pharma Ltd's share price is ₹1221.15 as of 2025-01-15.
What is the PE ratio of Natco Pharma Ltd?
Natco Pharma Ltd's P/E ratio is 11.57 times as of 2025-01-15.
What is the PB ratio of Natco Pharma Ltd?
Natco Pharma Ltd's most recent financial reports indicate a price-to-book ratio of 3.15, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Natco Pharma Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Natco Pharma Ltd's market capitalization is ₹22492.62 Cr as on 2025-01-15.
What is the ROE of Natco Pharma Ltd?
The current financial records of Natco Pharma Ltd show a 25.38% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Natco Pharma Ltd?
According to Natco Pharma Ltd's most recent financial filings, the company has a total asset value of ₹3462.3, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Natco Pharma Ltd?
The 52-week high/low price of a Natco Pharma Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Natco Pharma Ltd's 52-week high and low as of 2025-01-15 are ₹1267.9 and ₹1215.05, respectively.
